Given the common use of ACE inhibitors and ARBs worldwide, guidance on the use of these drugs in patients with Covid-19 is urgently needed. Here, we highlight that the data in humans are too limited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback